MAP2K1 and melorheostosis: Despite no pathogenic variant detected through exome sequencing, recent studies link melorheostosis to somatic mutations, particularly in the MAP2K1, which plays a crucial role in the RAS-MAPK signaling pathway, implicated in bone remodeling and sclerosis [9].